期刊文献+

N末端B型利钠肽原对单纯主动脉瓣关闭不全心力衰竭患者的诊断价值 被引量:7

The Diagnostic Value of N-Terminal Pro-B Type Natriuretic Peptide in Aortic Regurgitation Patients With Heart Failure
下载PDF
导出
摘要 目的:评价N末端B型利钠肽原(NT-proBNP)对单纯主动脉瓣关闭不全(AR)心力衰竭患者的诊断价值。方法:使用酶联免疫的方法对27例单纯AR心力衰竭患者(单纯AR心力衰竭组)和76例正常对照者(正常对照组)行NT-proBNP测定,评价其对单纯AR心力衰竭的诊断价值。结果:与正常对照组相比,单纯AR心力衰竭组的NT-proBNP水平显著升高(P<0.05),差异有统计学意义;纽约心功能分级(NYHA)Ⅰ、Ⅱ级者差异无统计学意义;NYHAⅢ级者显著升高5.2倍,也显著高于NYHAⅠ、Ⅱ级者,差异均有统计学意义。在左心室舒张期末内径(LVEDD)>60 mm者显著高于LVEDD≤60 mm者(P<0.05),在合并心房颤动者也显著高于窦性心律者(P<0.01),差异均有统计学意义。当NT-proBNP阈值在1 340 pg/ml时,是诊断单纯AR心力衰竭(受试者工作特性曲线下面积=0.699,P<0.01)的最佳阈值;诊断的敏感性、特异性和准确性分别为59.26%、96.05%和86.41%。单因素分析,Log(NT-proBNP)仅与心功能(P=0.002)和LVEDD(P=0.033)呈显著正相关;多元逐步回归分析只有心功能与NT-proBNP呈独立相关。结论:NT-proBNP对单纯AR心力衰竭患者有重要诊断价值。诊断单纯AR心力衰竭的最佳阈值为1 340 pg/ml,准确性高达86.41%。 Objective:To evaluate the diagnostic value of N-terminal pro-B type natriuretic peptide (NT-proBNP) in aortic regurgitation (AR) patients with heart failure. Methods:We summarized 27 AR patients with heart failure (Patient group) for blood level of NT-proBNP by ELISA, the pa- tients were treated in our hospital from 2005 to 2006, and meanwhile, took 76 normal subjects as Control group. The diagnostic value of NT-proBNP for heart failure was assessed and compared in both groups. Results : Blood level of NT-proBNP was significantly higher in Patient group than that in Control group, P 〈 0. 05, it was 5.2 times higher in patients with NYHA class m than those in Control group P 〈0. 01 and those in NYHA class I , II ,respectively. NT-proBNP was higher in patients with left ventricular end-diastolic diameter (LVEDD) 〉 60 mm than those with LVEDD ≤ 60 mm, P 〈 O. 05. It was higher in patients with atrial fibrillation than those with sinus rhythm,P 〈 0.01. The best cutoff value of NT-proBNP was 1 340 pg/ml for heart failure diagnosis (ROC =0. 699 ,P 〈0. 01 ) ,the sensitivity ,specificity and accuracy were59. 26% ,96. 05% and 86. 41% respectively. Univariate analysis indicated that Log(NT-proBNP) was positively related to cardiac function and LVEDD,P = 0. 002,P = 0. 033 respectively. Multiple regression analysis presented that NT-proBNP was positively related to cardiac function. Conclusion : NT-proBNP was important for diagnosing heart failure in AR patients, the best cutoff value was 1 340 pg/ml with the diagnostic accuracy of 86.41%.
出处 《中国循环杂志》 CSCD 北大核心 2011年第1期34-37,共4页 Chinese Circulation Journal
基金 北京市科委重大科技支撑项目(D0906004040291)
关键词 主动脉瓣关闭不全 心力衰竭 N末端B型利钠肽原 诊断 Aortic regurgitation Heart failure N-terminal pro-B type natriuretic peptide Diagnosis
  • 相关文献

参考文献16

  • 1Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med ,2002,347 : 161-167.
  • 2Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal proBNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol,2005 ,95 :948-954.
  • 3Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004.109,2302 -2308.
  • 4Eimer MJ, Ekery DL, Rigolin VH, et al. Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am J Cardiol,2004,94:676-678.
  • 5Gerber IL,Stewart RA, French JK, et al. Associations between plasma natriuretic peptide levels, symptoms, andleftventricular function in patients with chronic aortic regurgitation. Am J Cardiol,2003,92:755- 758.
  • 6Gerber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation, 2003,107 : 1884-1890.
  • 7Sutton TM, Stewart RA, Gerber IL, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coil Cardio1,2003 ,41:2280-2287.
  • 8Braunwald E. Biomarkers in heart failure. N Engl J Med,2008,358: 2148-2159.
  • 9Felker GM, Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure. CMAJ,2006,175:611-617.
  • 10冯莉,浦介麟,倪新海,赵兴山,孙华毅,杨跃进.N端心房利钠肽和N端B型利钠肽原对无症状左心室收缩功能障碍的早期预测价值[J].中国循环杂志,2010,25(4):273-276. 被引量:14

二级参考文献12

  • 1Romano S, Necozione S, Guarracini L, et al. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients. J Cardiovasc Med (Hagerstown) ,2009,10:238-244.
  • 2Hall C, Ihlen H, Bonarjee V, et al. N-terminal proatrial natriuretic peptide in primary care:relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease. Int J Cardiol, 2003,89 (2-3) :197-205.
  • 3Sanada H, Shimizu M, Shimizu K, et al. Left atrial afterload mismatch in hypertrophic cardiomyopathy. Am J Cardiol, 1991,68 (10) : 1049-1054.
  • 4Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med ,2002,347 : 161-167.
  • 5McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet,1997,350(9081 ) :829-833.
  • 6Vasan RS, Benyamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction. The Framingham Heart Study. JAMA,2002,288 ( 11 ) : 1252-1259.
  • 7Redfield MM, Rodeheffer ILl, Jacobsen SJ, et al. Plasma brain natriuretic peptidc to detect preclinieal ventricular systolic or diastolic dysfunction. A community-based study. Circulation, 2004, 109 ( 25 ) : 3176-3181.
  • 8Redfield MM,Jacobsen SJ,Burnett JC Jr,et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA ,2003,289( 2 ) :194-202.
  • 9Wang TJ, Levy D, Benjamin E J, et al. The epidemiology of "asymptomatic" left ventricular systolic dysfunction : implications for screening. Ann Intern Med,2003,138 ( 11 ) :907-916.
  • 10Lerman A, Gibbons R J, Rodeheffer R J, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet, 1993,341 ( 8853 ) : 1105-1109.

共引文献13

同被引文献115

引证文献7

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部